New Lonza facility set to support US biotechs in managing the path to commercialization of novel therapies 14-Feb-2023 By Jane Byrne Switzerland headquartered Lonza said it is expanding its early development services (EDS) to North America, opening a new laboratory in Cambridge, Massachusetts (US).